HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Fate Therapeutics (FATE) Investors to Securities Class Action, Encourages ...
San Francisco, California--(Newsfile Corp. - February 15, 2023) - Hagens Berman urges Fate Therapeutics, Inc. FATE investors who suffered significant losses to submit your losses now. Class Period: Apr. 2, 2020 - Jan. 5, 2023 Lead Plaintiff Deadline: Mar. …